 |
|
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online 2022 Sep 14 DOI: https://doi.org/10.3350/cmh.2022.0247
|
|
Citations to this article as recorded by
 Long-Term Survival and Recurrence in HCC vs. Non-HCC Liver Transplant Recipients: A Two-Decade Longitudinal Analysis
Mahmoudreza Moein, Bridgette Nixon, Michael Leyderman, Ali Bassir, Brenden Maloney, Abolfazl Jamshidi, Matin Moallem Shahri, Amin Bahreini, Alireza Golkarieh, Reza Saidi
Journal of Clinical and Experimental Hepatology.2025; 15(3): 102489. CrossRef Editorial: PIVKA‐II Facilitates Risk Stratification for HCC Following HCV Cure
Tung‐Hung Su, Wei‐Chih Liao
Alimentary Pharmacology & Therapeutics.2025; 61(3): 583. CrossRef NAFLD and NAFLD Related HCC: Emerging Treatments and Clinical Trials
Tripti Khare, Karina Liu, Lindiwe Oslee Chilambe, Sharad Khare
International Journal of Molecular Sciences.2025; 26(1): 306. CrossRef A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma
Shi-Chuan Tang, Kai-Ling Zhang, Kong-Ying Lin, Yi-Dan Tang, Jun Fu, Wei-Ping Zhou, Jian-Xi Zhang, Jie Kong, Xiao-Lu He, Zheng-Hong Sun, Cong Luo, Hong-Zhi Liu, Yong-Ping Lai, Yong-Yi Zeng
Hepatology International.2024; 18(2): 623. CrossRef A risk prediction model for hepatocellular carcinoma in non‐alcoholic fatty liver disease without cirrhosis
Gi‐Ae Kim, Yewan Park, Shin Ju Oh, Jooyi Jung, Seungbong Han, Hye‐Sook Chang, Sung Won Park, Tae Hyup Kim, Hye Won Park, Jaewon Choe, Jaeil Kim, Han Chu Lee
Liver International.2024; 44(3): 738. CrossRef Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease
Wei Ouyang, Ming-Da Wang, Ming-Cheng Guan, Yong-Kang Diao, Li-Yang Sun, Nan-Ya Wang, Feng Shen, Hong Zhu, Tian Yang
iLIVER.2024; 3(2): 100098. CrossRef A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions
Yang Ma, Jinguo Wang, Wenping Xiao, Xiaoming Fan
Frontiers in Medicine.2024;[Epub] CrossRef Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
Clinical and Molecular Hepatology.2024; 30(3): 360. CrossRef Association of physical activity, including amount and maintenance, with the risk of HCC among patients with type 2 diabetes
Wonkyung Han, Kyungdo Han, Seong Gyu Hwang, Sang Hoon Ahn, Mi Na Kim
JHEP Reports.2024; 6(10): 101166. CrossRef MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed
Current Issues in Molecular Biology.2024; 46(6): 5965. CrossRef Mapping the Hidden Terrain of Hepatocellular Carcinoma: Exploring Regional Differences in Incidence and Mortality across Two Decades by Using the Largest US Datasets
Yazan Abboud, Vraj P. Shah, Michael Bebawy, Ahmed Al-Khazraji, Kaveh Hajifathalian, Paul J. Gaglio
Journal of Clinical Medicine.2024; 13(17): 5256. CrossRef Unveiling key drivers of hepatocellular carcinoma: a synergistic approach with network pharmacology, machine learning-driven ligand discovery and dynamic simulations
D.K. Sabir, J.A. Bin Jumah, I. Ancy
SAR and QSAR in Environmental Research.2024; 35(11): 1045. CrossRef Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
Liver International.2023; 43(3): 608. CrossRef Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Clinical and Molecular Hepatology.2023; 29(2): 404. CrossRef The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 355. CrossRef Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis
Mohamed Salaheldin, Heba Aly, Louis Lau, Shimaa Afify, Mohamed El-Kassas
Diagnostics.2023; 13(16): 2631. CrossRef
|